Introduction
Styrene is widely used in the plastic and rubber industry (Miller et al., 1994; IARC, 2002) . Human exposure to styrene occurs mainly in manufacturing sites particularly in developing countries. Animal studies have shown that styrene produced hepatotoxicity and pneumotoxicity in rodents, and styrene is classified as a possible carcinogen (IIB) in humans (Bond, 1989; IARC, 2002) . The metabolism of styrene has been extensively investigated. Epoxidation of the vinyl group is the primary oxidation reaction by which styrene is metabolized to styrene-7,8-oxide (SO, 2, Scheme 1) (Bond, 1989; Sumner and Fennell, 1994) . The oxidative metabolite has been reported to be mutagenic and carcinogenic (IARC, 1985; Gadberry et al., 1996) .
Aromatic hydroxylation of styrene has been reported, and it is considered to be a minor metabolism pathway of styrene (Bond, 1989; Sumner and Fennell, 1994; Vodicka et al., 2006) . Urinary 4-vinylphenol (4-VP) and its glucuronide and sulfate conjugates were detected in urine of rats treated with styrene (Bakke and Scheline, 1970; Pantarotto et al., 1978) . These metabolites were also detected in urine of workers in reinforced plastic plants (Pfaffli et al., 1981; Manini et al., 2003) . 2-Vinylphenol (2-VP) and 3-vinylphenol (3-VP) have been proposed as aromatic hydroxylation products of styrene (Sumner and Fennell, 1994) , but they have never been identified either in experimental animals or in humans exposed to styrene. Most recently, Linhart and coworkers reported urinary 3-VP, 4-VP, and possible 2-VP in mice exposed to airborne styrene (Linhart et al., 2010) . Cruzan et al. stated that differences in styrene oxide blood concentration did not account for the species selectivity and tumor response to styrene.
Styrene is tumorigenic in mouse lung, but not rat lung. This author also suggested that there were other metabolites generated from styrene by CYP2F2 and that these may be responsible for tumor formation in murine lung (Cruzan, et al., 2009) Animal studies showed that 4-VP was more hepatotoxic and pneumotoxic than styrene or SO when these compounds were administered to CD-1 mice intraperitoneally . This led us to examine the formation of 2-VP and 3-VP from styrene and their toxicities to pulmonary system. Our hypothesis is that 2-VP and 3-VP are metabolites of styrene and may be contributors to styrene-induced toxicity.
. Identification of the
The formation of 4-VP from styrene has been well documented, but CYP isoforms responsible for styrene ring oxidation is unclear. CYP2F2 and CYP2E1 were found to be the principal isoforms to catalyze the biotransformation of styrene to SO in mice (Hynes et al., 1999; Cruzan et al., 2002; Carlson, 2003) . We hypothesize that CYP2F2 and CYP 2E1 also participate in styrene ring oxidation.
Rapid disappearance of 4-VP was observed by Carlson's group when this substrate was incubated with mouse liver microsomes , but the metabolic fate of 4-VP remains unknown. They also found that inhibition of 4-VP metabolism by 5-phenyl-1-pentyne (5P1P) significantly inhibited the toxicity of 4-VP in rats and mice , indicating that metabolic activation was involveed in 4-VP-induced toxicity. Pantarotto and co-workers reported 4-VP-derived metabolites 4-hydroxystyrene glycol, 4-hydroxymandelic acid, 4-VP glucuronide and sulfate in urine of workers after exposure to styrene (Pantarotto et al., 1978; Manini et al., 2003) . This result implied 4-VP underwent similar metabolism pathways with that of styrene, i.e. vinyl epoxidation and ring epoxidation.
In the present study, we characterized new styrene metabolites, including 2-VP, 3-VP, vinyl-1,4-hydroquinone, and 2-hydroxystyrene glycol in mouse microsomal incubations and identified the possible enzymes responsible for aromatic hydroxylation of styrene. We also evaluated the pulmonary toxicity of 2-VP, 3-VP and 4-VP along with This article has not been copyedited and formatted. The final version may differ from this version. 
Synthesis of 2-VP (4) and 3-VP (5):
To a solution of 250 mg of 2-vinylanisole dissolved in 10 mL anhydrous DMF was added 300 mg sodium thiomethoxide, and the mixture was refluxed until TLC showed 2-vinylanisole was consumed. The reaction mixture was diluted with 10 mL water, acidized to pH 2 with 1 N HCl and extracted with CH 2 Cl 2 (15 mL × 3). The resulting extracts were washed with water (15 mL × 3) and dried on anhydrous Na 2 SO 4 , followed by rotary evaporation. (Ph 3 PCH 3 I) suspended in 10 mL anhydrous THF was added 100 mg sodium hydride (60%). After stirring at room temperature for 1 h, 100 mg of 2,3-dimethoxymethoxybenzaldehyde was added and the reaction was refluxed for 2 h, after the resulting mixture was cooled to room temperature, it was poured into 15 mL of water.
The mixture was extracted with chloroform (15 mL × 3), and the solvent was evaporated under vacuum. An oily liquid characterized as 2,3-bis(methoxymethoxy)styrene was 3-Vinylcatechol (7), 4-vinylcatechol (9) and vinyl-1,4-hydroquinone (8) showed the same ion fragments (m/z 280 and 265) with different retention times (Table S1 , one week before experiment and were housed in an air conditioned room set to maintain 20-24°C, 40-60% relative humidity, and 12-h light/dark cycle.
Preparation of microsomes:
Male CD-1 mice were terminated by CO 2 . Blood was drawn from the heart with a syringe. Livers and lungs were harvested and rinsed with ice-cold 0.1 M phosphate buffer, pH 7.4. The livers or lungs were pooled and weighed, homogenized in ice-cold 0.1 M phosphate buffer (4 mL/g tissue). Microsomes were prepared by differential centrifugation. The homogenate was centrifuged at 3,000 × g for 15 min, followed by centrifugation of the resulting supernatant at 12,000 × g for 30 min.
Then the resultant supernatant was centrifuged at 105,000 × g for 60 min. The pellets of microsomal preparations were resuspended in ice-cold 0.1 M phosphate buffer. Protein contents were determined by Pierce 660 nm Protein Assay (Pierce, Rockford, IL). The microsomes were stored in -80°C freezer until use.
Detection of phenolic metabolites of styrene in mouse microsomal incubations:
Incubations were carried out in glass tubes with PTFE-faced rubber-lined screw caps (10 × 1.3 cm id, Kimble Chase, Vineland, NJ). The incubation mixtures contained mouse liver or lung microsomes (1 mg protein/mL), 5 mM MgCl 2 , 2 mM NADPH, 500 µM styrene, 50 mM phosphate buffer (pH 7.4) with a total volume of 0.5 mL. After preincubation in a 37°C water bath shaker for 3 min, reactions were initiated by adding of 5 µL of styrene solution (50 mM in DMSO) and the reaction tubes were capped immediately. Some microsomal incubations were done with a total volume of 8.0 mL reaction mixture, and some incubations excluded NADPH as blank control.
After incubation for 20 min, the reactions were terminated by adding 3 mL of icecold ethyl acetate, followed by addition of 5 µL of internal standard solution containing In order to directly detect metabolites of VPs as secondary metabolites of styrene, large-scaled mouse microsomal incubations were performed. The incubation volume was 8 mL, and the protein concentration was 1 mg/mL for mouse liver microsomes and 0.5 mg/mL for mouse lung microsomes. The concentrations of other components remained the same as those for the small-scaled (0.5 mL) incubations.
Inhibition of styrene metabolism in mouse microsomal incubations: To investigate whether CYP2E1 or CYP2F2 was involved in the production of VPs from styrene, 100
µM of disulfiram (inhibitor of CYP2E1) (Emery et al., 1999; Frye and Branch, 2002) or 5 µM of 5-phenyl-1-pentyne (5P1P, inhibitor of CYP2F2 and CYP2E1) (Roberts et al., 1998; Green et al., 2001; Carlson, 2004) were incorporated into mouse liver or lung microsomes. The other components were the same as those for the incubations without the inhibitors described above. After all components except styrene were mixed in test tubes, samples were preincubated at 37°C for 15 min, followed by addition of styrene and incubation for another 20 min. Samples were processed in the same way as described above. 
GC/MS analysis:
The column temperature was held at initial temperature 60°C for 1 min after injection of 1 µL sample, followed by an increase to 170°C at 10°C/min, then increased at 20°C/min to 250°C and held for 2 min. Injector port temperature was 250°C
and detector temperature was 280°C. Carrier gas was helium with column head pressure set at 10 psi at 50°C. Target Toxicity of styrene, SO, and VPs in CD-1 mice: Adult male CD-1 mice were divided into 6 groups of 3 mice each. The control group was injected with propylene glycol intraperitoneally at 5 mL/kg. The other five groups were treated with styrene, SO, 2-VP, 3-VP, or 4-VP at a dose of 100 mg/kg intraperitoneally. The dose solution was dissolved in propylene glycol and administered at a volume of 5 mL/kg. After 24 h, the mice were sacrificed by CO 2 asphyxiation; the trachea was exposed, where a small nick was made and an oral feeding needle was inserted and tied in place. The lungs were lavaged twice with 0.9 mL of room-temperature PBS (Mediatech Inc., Manassas, VA). The bronchoalveolar lavage fluid (BALF) was collected (1.6 mL). Cells in BALF were counted using a hemocytometer with a microscope. The remaining BALF from each mouse was Table S1 .
Detection of phenolic metabolites of styrene in microsomal incubations:
In an effort to detect the phenolic metabolites, styrene was incubated in mouse liver or lung microsomes for 20 min. As expected, styrene glycol (3) and 4-VP (6) were observed by GC/MS. Additionally, we detected 2-VP (4) and 3-VP (5) in liver microsomal incubations.
Styrene glycol, the hydrated product of SO, was the predominant metabolite of styrene, while 2-VP, 3-VP and 4-VP, the aromatic hydroxylation products, were minor metabolites relative to styrene glycol. As shown in Figure 1B , the detected metabolites showed the same retention times and same ion fragments (m/z 177 and 192) as that of the corresponding authentic standards ( Figure 1D ) in GC/MS. The samples analyzed above were spiked with a mixture of authentic 2-VP, 3-VP, and 4-VP and re-analyzed by GC/MS. As expected, increases in peak areas of those peaks with the same retention times as that of the authentic VPs spiked were observed, but no new peaks were detected ( Figure 1C ). This co-elution test confirmed the production of the individual VPs in the microsomal incubations. No such peaks with the same retention times were observed in the incubations without NADPH ( Figure 1A ). Metabolites SG, 2-VP, 3-VP and 4-VP were also detected in mouse lung microsomal incubations, although the amount was less than that in mouse liver microsomes ( Figure S1 ). In large scale microsomal incubations (final volume: 8 mL) with styrene, SG (3) and three VPs (4-6) were detected as expected. Additionally, vinyl-1,4-hydroquinone (8), 2-hydroxystyrene glycol (10) and 4-hydroxystyrene glycol (12) were identified in mouse liver microsomal incubations (Figure 2 ), while only 2-hydroxystyrene glycol along with three VPs and SG were observed in mouse lung microsomal incubations (data not shown).
CYP inhibition of styrene metabolism in mouse microsomes:
The rates of VP and SG production in mouse liver and lung microsomal incubations with or without inhibitor are listed in Table 1 and Table 2 . The ratios of VPs/SG production were calculated to determine the attribution of vinyl and aromatic oxidation in styrene metabolism. Larger ratios of VPs/SG were observed in mouse lung microsomes than in mouse liver microsomes. Among the phenolic metabolites generated, 2-VP was formed at a rate of 10-fold faster than that of 3-VP and 4-VP in both mouse liver and lung microsomal incubations. However, metabolism of styrene was slower in mouse lung microsomes than in mouse liver microsomes. Specifically, the rate of SG formation in mouse lung microsomes was 5.7-fold lower than that in mouse liver microsomes, while the rates for the formation of VPs were only 2-fold lower.
In order to investigate the involvement of CYP2E1 and CYP2F2 in the production of VPs, disulfiram (inhibitor of CYP2E1) or 5P1P (inhibitor of CYP2F2 and CYP2E1) was incorporated into the mouse liver and lung microsomal incubations. Both disulfiram (100.0 µM) and 5P1P (5.0 µM) inhibited VPs and SG production in mouse liver and lung microsomes (Table 1 and Table 2 ). Interestingly, the formation of VPs and SG was almost completely inhibited by 5P1P in lung microsomal incubations.
Metabolism of VPs in mouse microsomes:
In order to investigate the metabolism of VPs, individual VPs were incubated with mouse liver microsomes. Figure S1 This article has not been copyedited and formatted. The final version may differ from this version. (8) were detected in the microsomes incubated with 2-VP ( Figure 3A) ; 3-vinylcatechol (7), vinyl-1,4-hydroquinone (8) and 4-vinylcatechol (9) were detected in the microsomal incubations with 3-VP ( Figure 3B ); and 4-vinylcatechol (9) was detected in the microsomes after exposure to 4-VP ( Figure   3C ). Additionally, the three VPs were metabolized to the corresponding glycols ( Figure   4 ). All metabolites were characterized by comparing their retention times and ion fragments with that of the corresponding authentic standards in GC/MS.
Our results indicate that, like styrene, VPs undergo two metabolism pathways.
One is vinyl epoxidation, and the other involves aromatic hydroxylation. Vinyl epoxidation produces epoxides which are further transformed to glycols by spontaneous or enzymatic hydration. The aromatic hydroxylation affords catechols and hydroquinone. Table S2 (Supplemental Data) shows the peak area ratios of VPs metabolites v.s.
internal standard SG-d 8 and the ratios were used to estimate the production of metabolites. Based on this semi-quantitative analyses, 3-VP was preferentially metabolized by aromatic hydroxylation resulting in vinyl-1,4-hydroquinone. However, 4-VP was mostly metabolized by vinyl of the oxidation, thus generating glycol; 2-VP was metabolized to both catechols/hydroquinone and glycol at similar rates.
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Discussion
Metabolism of styrene apparently includes two pathways, i.e. vinyl epoxidation and aromatic hydroxylation. The former offers styrene-7,8-oxide (SO, 2) reported as the primary metabolite of styrene, and the later produces styrene-derived phenols. Urinary 4-VP (6) and its conjugates have been identified in rodents given styrene and in workers exposed to styrene (Bakke and Scheline, 1970; Pantarotto et al., 1978; Pfaffli et al., 1981; Manini et al., 2003) . Based on the knowledge of general chemistry, we reasoned that aromatic hydroxylation of styrene would generate three isomers of styrene-derived phenols, i.e. 2-VP, 3-VP and 4-VP (Scheme 1).
In the present studies, we detected all three phenols in styrene microsomal incubations containing styrene. Surprisingly, 2-VP was found to be the dominant metabolite among the three VPs detected. The ratio of the detected 2-VP, 3-VP and 4-VP was 27.7: 1.0 : 2.8 in mouse liver microsome. Recently, Linhart et al. reported the detection of urinary 3-VP, 4-VP, possible 2-VP, and mercapturic acids derived from styrene-3,4-oxide and styrene-2,3-oxide in mice given styrene (Linhart et al., 2010) .
They found approximate 3-fold more mercapturic acid derived from styrene-3,4-oxide than that derived from styrene-2,3-oxide in the urine, inferring that styrene-3,4-oxide dominated in the formation of styrene arene oxides. This is inconsistent with what we observed in mouse microsomal incubations (the VPs are presumably derived from the corresponding oxides).
Higher VPs/SG value (3-fold) was observed in lung microsomal incubations than in liver microsomal incubations. This implies that microsomal enzymes in mouse lung tend to favor the catalysis of aromatic hydroxylation of styrene in comparison with microsomal enzymes in mouse liver, although styrene oxide was found to be the predominant metabolite of styrene in both liver and lung microsomal incubations, and the 21 absolute amount of SG and VPs generated in liver microsomes was higher than that formed in lung microsomes (5.7-fold for SG and 1.9-fold for VPs).
CYP2F2 and CYP2E1 have been reported to be involved in metabolic activation of styrene in mice (Hynes et al., 1999; Cruzan et al., 2002; Carlson, 2003) . CYP2E1 is predominantly expressed in liver with lower levels in other tissue such as lung (Choudhary et al., 2003; Choudhary et al., 2005) , while CYP2F2 is expressed both in liver and lung with a little higher expression in lung (Powley and Carlson, 2001; Baldwin et al., 2004) . Our inhibition experiments showed that both disulfiram and 5P1P inhibited VP and SG production in mouse liver microsomes. However, 5P1P caused substantial decrease in VPs/SG value, while disulfiram did not (Table 1) . Disulfiram is a known CYP2E1 inhibitor and 5P1P has been reported to inhibit both CYP2F2 and CYP2E1.
The observation of substantial drop of VPs/SG value by co-incubation with 5P1P
indicates that CYP2F2 may be more important to catalyze the biotransformation of styrene to VPs relative to CYP2E1 especially in mouse lung.
Metabolism of VPs was investigated in mouse liver microsomes, and a total of three aromatic hydroxylated products, including 3-vinylcatechol, 4-vinylcatechol and/or vinyl-1,4-hydroquinone, along with glycols derived from the corresponding VPs, were detected. As shown in Figure 3 and 4, microsomal incubations with 4-VP gave one hydroxylated product identified as 4-vinylcatechol (9). Two hydroxylated products were detected and characterized as 3-vinylcatechol (7) and vinyl-1,4-hydroquinone (8) in microsomes after incubation with 2-VP. All the three hydroxylated products (the only possibilities) observed in microsomal incubations with 2-VP or 4-VP were detected in microsomal incubations with 3-VP. These VPs are good substrates for hydroxylation at positions ortho or para to their phenolic hydroxyl groups. This is consistent with the generally electrophilic character of CYP enzymes (Zheng and Hanzlik, 1992) .
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Specifically, as shown in Scheme 2, 2-VP undergoes hydroxylation at C-4 and C-6, 3-VP undergoes hydroxylation at C-2, C-4 and C-6, and the symmetrical 4-VP undergoes hydroxylation at C-2(6). Alternatively, all three VPs were metabolized to the corresponding epoxides via oxidation at the vinyl groups and sequentially to the corresponding glycols (10-12) through spontaneous hydration. In parallel, the three VPs were incubated with mouse liver microsomes in the absence of NAPDH. As expected, no disappearance of the parent compounds was observed.
We scaled up microsomal incubations of styrene, and this allowed us to obtain sufficient amounts of the secondary metabolites of styrene for GC/MS detection. In up- (Bond, 1989; Sumner and Fennell, 1994) . The observed vinyl-1,4-hydroquinone may be spontaneously oxidized to vinyl-1,4-benzoquinone (Scheme 2) (Shen et al., 1997) . Both epoxides and quinones are known toxic species. However, the role of these metabolites in styrene-induced cytotoxicity remains unknown.
The toxicity of 4-VP has been well documented, and 4-VP was found to be more toxic than styrene and styrene oxide. It has been speculated that 4-VP formed in situ is involved in styrene-induced cytotoxicity in mice. This encouraged us to evaluate the pulmonary toxicity of 2-VP and 3-VP. The pulmonary toxicities of styrene, SO, and the three VPs were evaluated in CD-1 mice. 4-VP showed the highest toxicity among these chemicals. Although the three VPs have similar structure, it appears that 2-VP and 3-VP were less toxic than 4-VP (Table 3) . However, 10-fold higher 2-VP production than that of 4-VP was observed both in liver and lung microsomal incubations. The toxicological role of 2-VP in styrene-induced toxicity should not be neglected, due to its high production. The proportion of the chemicals for the pulmonary toxicity studies to reach the lung may not necessarily the same. We speculate that significant portions of the vinyl phenols are depleted through glucuronidation/sulfation conjugation (first-pass effect) in the liver before they arrive at the target organ, while styrene does not undergo the conjugation.
In conclusion, new styrene metabolites 2-VP, 3-VP, vinyl-1,4-hydroquinone, and 2-hydroxystyrene glycol were identified in mouse liver microsomal incubations. CYP2F2
and CYP2E1 were found to catalyze the formation of VPs and SO from styrene in mouse liver and lung microsomes. The detected 2-VP, 3-VP, and 4-VP were further oxidized to the corresponding catechols and/or hydroquinone by aromatic hydroxylation and to the corresponding oxides by vinyl epoxidation. 2-Vinylphenol and 3-VP were not as toxic as 4-VP to pulmonary system in mice. However, the potential toxicity of 10-fold higher production of 2-VP than that of 4-VP in mouse liver and lung microsomal incubations of styrene should not be neglected.
This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. 
